These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 34146731)

  • 41. Molecular Basis of Mink ACE2 Binding to SARS-CoV-2 and Its Mink-Derived Variants.
    Su C; He J; Han P; Bai B; Li D; Cao J; Tian M; Hu Y; Zheng A; Niu S; Chen Q; Rong X; Zhang Y; Li W; Qi J; Zhao X; Yang M; Wang Q; Gao GF
    J Virol; 2022 Sep; 96(17):e0081422. PubMed ID: 36000849
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comprehensive mapping of binding hot spots of SARS-CoV-2 RBD-specific neutralizing antibodies for tracking immune escape variants.
    Yi C; Sun X; Lin Y; Gu C; Ding L; Lu X; Yang Z; Zhang Y; Ma L; Gu W; Qu A; Zhou X; Li X; Xu J; Ling Z; Xie Y; Lu H; Sun B
    Genome Med; 2021 Oct; 13(1):164. PubMed ID: 34649620
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mutation profile of SARS-CoV-2 genome in a sample from the first year of the pandemic in Colombia.
    Gálvez JM; Chaparro-Solano HM; Pinzón-Rondón ÁM; Albornoz LL; Pardo-Oviedo JM; Zapata-Gómez FA; Patiño-Aldana AF; Hernández-Rodríguez ADP; Díaz-Quiroz M; Ruiz-Sternberg ÁM
    Infect Genet Evol; 2022 Jan; 97():105192. PubMed ID: 34933126
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7.
    Wang P; Nair MS; Liu L; Iketani S; Luo Y; Guo Y; Wang M; Yu J; Zhang B; Kwong PD; Graham BS; Mascola JR; Chang JY; Yin MT; Sobieszczyk M; Kyratsous CA; Shapiro L; Sheng Z; Huang Y; Ho DD
    Nature; 2021 May; 593(7857):130-135. PubMed ID: 33684923
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mutations in membrane-fusion subunit of spike glycoprotein play crucial role in the recent outbreak of COVID-19.
    Podder S; Ghosh A; Ghosh T
    J Med Virol; 2021 May; 93(5):2790-2798. PubMed ID: 33090493
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K and N501Y variants by BNT162b2 vaccine-elicited sera.
    Xie X; Liu Y; Liu J; Zhang X; Zou J; Fontes-Garfias CR; Xia H; Swanson KA; Cutler M; Cooper D; Menachery VD; Weaver SC; Dormitzer PR; Shi PY
    Nat Med; 2021 Apr; 27(4):620-621. PubMed ID: 33558724
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Distinct shifts in site-specific glycosylation pattern of SARS-CoV-2 spike proteins associated with arising mutations in the D614G and Alpha variants.
    Kuo CW; Yang TJ; Chien YC; Yu PY; Hsu SD; Khoo KH
    Glycobiology; 2022 Feb; 32(1):60-72. PubMed ID: 34735575
    [TBL] [Abstract][Full Text] [Related]  

  • 48. SARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in vitro evolution.
    Zahradník J; Marciano S; Shemesh M; Zoler E; Harari D; Chiaravalli J; Meyer B; Rudich Y; Li C; Marton I; Dym O; Elad N; Lewis MG; Andersen H; Gagne M; Seder RA; Douek DC; Schreiber G
    Nat Microbiol; 2021 Sep; 6(9):1188-1198. PubMed ID: 34400835
    [TBL] [Abstract][Full Text] [Related]  

  • 49. SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity.
    Motozono C; Toyoda M; Zahradnik J; Saito A; Nasser H; Tan TS; Ngare I; Kimura I; Uriu K; Kosugi Y; Yue Y; Shimizu R; Ito J; Torii S; Yonekawa A; Shimono N; Nagasaki Y; Minami R; Toya T; Sekiya N; Fukuhara T; Matsuura Y; Schreiber G; ; Ikeda T; Nakagawa S; Ueno T; Sato K
    Cell Host Microbe; 2021 Jul; 29(7):1124-1136.e11. PubMed ID: 34171266
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Physicochemical effect of the N501Y, E484K/Q, K417N/T, L452R and T478K mutations on the SARS-CoV-2 spike protein RBD and its influence on agent fitness and on attributes developed by emerging variants of concern.
    Pondé RAA
    Virology; 2022 Jul; 572():44-54. PubMed ID: 35580380
    [TBL] [Abstract][Full Text] [Related]  

  • 51. COVID-19 CG enables SARS-CoV-2 mutation and lineage tracking by locations and dates of interest.
    Chen AT; Altschuler K; Zhan SH; Chan YA; Deverman BE
    Elife; 2021 Feb; 10():. PubMed ID: 33620031
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Impact of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variant-Associated Receptor Binding Domain (RBD) Mutations on the Susceptibility to Serum Antibodies Elicited by Coronavirus Disease 2019 (COVID-19) Infection or Vaccination.
    Chen LL; Lu L; Choi CY; Cai JP; Tsoi HW; Chu AW; Ip JD; Chan WM; Zhang RR; Zhang X; Tam AR; Lau DP; To WK; Que TL; Yip CC; Chan KH; Cheng VC; Yuen KY; Hung IF; To KK
    Clin Infect Dis; 2022 May; 74(9):1623-1630. PubMed ID: 34309648
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Higher infectivity of the SARS-CoV-2 new variants is associated with K417N/T, E484K, and N501Y mutants: An insight from structural data.
    Khan A; Zia T; Suleman M; Khan T; Ali SS; Abbasi AA; Mohammad A; Wei DQ
    J Cell Physiol; 2021 Oct; 236(10):7045-7057. PubMed ID: 33755190
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Characterization of SARS-CoV-2 worldwide transmission based on evolutionary dynamics and specific viral mutations in the spike protein.
    Liu J; Chen X; Liu Y; Lin J; Shen J; Zhang H; Yin J; Pu R; Ding Y; Cao G
    Infect Dis Poverty; 2021 Aug; 10(1):112. PubMed ID: 34419160
    [TBL] [Abstract][Full Text] [Related]  

  • 55. SARS-CoV-2 variants, spike mutations and immune escape.
    Harvey WT; Carabelli AM; Jackson B; Gupta RK; Thomson EC; Harrison EM; Ludden C; Reeve R; Rambaut A; ; Peacock SJ; Robertson DL
    Nat Rev Microbiol; 2021 Jul; 19(7):409-424. PubMed ID: 34075212
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Functional Antibodies Against SARS-CoV-2 Receptor Binding Domain Variants with Mutations N501Y or E484K in Human Milk from COVID-19-Vaccinated, -Recovered, and -Unvaccinated Women.
    Demers-Mathieu V; Hakansson AP; Hall S; Lavangnananda S; Fels S; Medo E
    Breastfeed Med; 2022 Feb; 17(2):163-172. PubMed ID: 34809492
    [No Abstract]   [Full Text] [Related]  

  • 57. Development of an efficient Sanger sequencing-based assay for detecting SARS-CoV-2 spike mutations.
    Lim HJ; Park MY; Jung HS; Kwon Y; Kim I; Kim DK; Yu N; Sung N; Lee SH; Park JE; Yang YJ
    PLoS One; 2021; 16(12):e0260850. PubMed ID: 34905589
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evolution of SARS-CoV-2 Envelope, Membrane, Nucleocapsid, and Spike Structural Proteins from the Beginning of the Pandemic to September 2020: A Global and Regional Approach by Epidemiological Week.
    Troyano-Hernáez P; Reinosa R; Holguín Á
    Viruses; 2021 Feb; 13(2):. PubMed ID: 33557213
    [TBL] [Abstract][Full Text] [Related]  

  • 59. SARS-CoV-2 variants combining spike mutations and the absence of ORF8 may be more transmissible and require close monitoring.
    Pereira F
    Biochem Biophys Res Commun; 2021 Apr; 550():8-14. PubMed ID: 33676232
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Genetic Variant of SARS-CoV-2: would It Matter for Controlling the Devastating Pandemic?
    Guo S; Liu K; Zheng J
    Int J Biol Sci; 2021; 17(6):1476-1485. PubMed ID: 33907511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.